The Effect of Kerokan to Liver Function of Hepatitis B Patients

Nur Adiba Hanum, Ismalayani Ismalayani, Rahmad Aswin Juliansyah, Syokumawena Syokumawena, Marta Pastari, Hanna Sari Widya Kusuma, Yukko Arinta

Abstract


Kerokan is an alternative therapy done by rubbing and pressing the skin surface using oil and a blunt object. This treatment has a hepatoprotective effect as it increases heme oxygenase-1, an essential enzyme in heme catabolism. In hepatitis B, heme oxygenase-1 plays a vital role to fight oxidative stress. Hence the damage on liver cells can be reduced or even prevented. Damaged cells indicate by the production of aspartate aminotransferase (AST/SGOT) and alanine aminotransferase (ALT/SGPT) enzymes that accumulated in the bloodstream. This study aimed to investigate the effect of kerokan to liver function by analyzing SGOT and SGPT levels in hepatitis B patients. These were an experimental study with a pre-test post-test control group design conducted in the public health center in Palembang in October 2016. Statistical analysis used the unpaired t test and paired. The research subjects were 30 patients with inactive carrier and chronic hepatitis B. The levels of SGOT and SGPT were determined using the IFCC method. The levels of SGOT in control (19.53±3.44 U/L) and treatment group (20.46±4.53 U/L, Δ=0.93) after 24–48 hours were not statistically different (p=0.53). Also, the levels of SGPT in control (18.66±5.40 U/L) and treatment group (19.80±9.25 U/L, Δ=1.13) after 24–48 hours were also not statistically different (p=0.68) as well. In conclusion, the liver cells of inactive carrier and chronic hepatitis B patients were not damaged (necrosis) after kerokan therapy, and the levels of SGOT and SGPT were still in the normal range.

 

EFEK KEROKAN TERHADAP FUNGSI HEPAR PASIEN HEPATITIS B

Kerokan merupakan terapi alternatif yang dilakukan dengan menggosok dan menekan permukaan kulit menggunakan minyak dan benda tumpul. Pengobatan ini bersifat hepatoprotektif, yaitu meningkatkan produksi enzim heme oxygenase-1 dalam katabolisme heme. Pada hepatitis B, heme oxygenase-1 berperan penting dalam menangkal radikal bebas sehingga dapat mengurangi atau mencegah kerusakan sel hepar. Kerusakan sel hepar diindikasikan oleh produksi enzim aspartate aminotransferase (AST/SGOT) dan alanine aminotransferase (ALT/SGPT) yang terakumulasi dalam pembuluh darah. Penelitian ini bertujuan mengetahui pengaruh kerokan pada fungsi hepar dengan menganalisis kadar SGOT dan SGPT pada pasien hepatitis B. Penelitian eksperimental ini menggunakan desain pre-test post-test control group yang dilakukan di puskesmas di Palembang pada Oktober 2016. Analisis statistik menggunakan uji t berpasangan dan tidak berpasangan. Subjek penelitian meliputi 30 pasien inactive carrier dan kronik hepatitis B. Kadar SGOT dan SGPT diukur dengan menggunakan metode IFCC. Kadar SGOT pada kontrol (19,53±3,44 U/L) dan grup perlakuan (20,46±4,53 U/L; Δ=0,93) setelah 24–48 jam tidak terdapat perbedaan signifikan (p=0,53). Selain itu, kadar SGPT pada kontrol (18,66±5,40 U/L) dan grup perlakuan (19,80±9,25 U/L; Δ=1,13) setelah 24–48 jam tidak menunjukkan perbedaan signifikan (p=0,68). Simpulan, sel hepar pada pasien inactive carrier dan kronik hepatitis B tidak mengalami kerusakan setelah terapi kerokan, serta kadar SGOT dan SGPT tetap dalam kondisi normal.


Keywords


Hepatitis B; kerokan; SGOT; SGPT

Full Text:

PDF

References


Nielsen A , Kaptchuk TJ. Gua sha: a traditional technique for modern practice. 2nd Edition. London: Churchill Livingstone; 2013.

Chan ST, Yuen JWM, Gohel MDI, Chung CP, Wong HC, Kwong KK. Guasha-induced hepatoprotection in chronic active hepatitis B: a case study. Clin Chim Acta. 2011;412(17–18):1686–8.

Kwong KK, Kloetzer L, Wong KK, Ren JQ, Kuo B, Jiang Y, et al. Bioluminescence imaging of heme oxygenase-1 upregulation in the Gua Sha procedure. J Vis Exp. 2009;(30):1385.

Wang G, Hamid T, Keith RJ, Zhou G, Partridge CR, Xiang X, Kingery JR, et al. Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart. Circulation. 2010;121(17):1912–25.

Pae HO, Chung HT. Heme oxygenase-1: its therapeutic roles in inflammatory diseases. Immune Netw. 2009;9(1):12–9.

Origassa CST, Câmara NOS. Cytoprotective role of heme oxygenase-1 and heme degradation derived end products in liver injury. World J Hepatol. 2013;5(10):541–9.

Ishikawa T. Immunoregulation of hepatitis B virus infection—rationale and clinical application. Nagoya J Med Sci. 2012;74(3–4):217–32.

Soemohardjo S, Gunawan S. Hepatitis B kronik. In: Setiati S, Alwi I, Sudoyo AW, Simadibrata M, Setiyohadi B, Syam AF, editors. Buku ajar ilmu penyakit dalam. 6th Edition. Jakarta: Interna Publishing; 2014. p. 1963–71.

Dahlan MS. Statistik untuk kedokteran dan kesehatan: deskriptif, bivariat, dan multivariat, dilengkapi aplikasi dengan menggunakan SPSS. 5th Edition. 3rd Print. Jakarta: Salemba Medika, 2013.

Schmidt WN, Mathahs MM, Zhu Z. Heme and HO-1 inhibition of HCV, HBV, and HIV. Front Pharmacol. 2012;3:129.

Chan ST, Yuen JWM, Gohel MDI, Wong HC, Chung CP, Sun Y, et al. Does guasha offer hepatoprotective effect to chronic inactive hepatitis b carriers? A built-in design to control subject expectation. J Altern Complement Med. 2013;19(9):772–6.




DOI: https://doi.org/10.29313/gmhc.v7i1.3397


pISSN 2301-9123 | eISSN 2460-5441

Visitor since 19 October 2016:

View My Stats

Free counters!

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.